Concepedia

Marie‐Emilie Willemin

MW

Statistics

Publications

10

Citations

211

H-Index

10

Active since

1984

Affiliations

Janssen (Belgium)(Current)

Institut national de l'environnement industriel et des risques

Centre National de la Recherche Scientifique

Johnson & Johnson (United States)

United States Food and Drug Administration

Marie‐Emilie Willemin is an author at Janssen (Belgium) specializing in drug disposition, pharmacy, and pharmacology.

ORCID

Publications per year

1984–2023

10

Publications

10

Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug–Drug Interactions

Marie‐Emilie Willemin, Thomas K. van der Made, Ils Pijpers et al. · Clinical Pharmacokinetics · 2021 · 47 citations · Full text

, , +14

PBPK modeling of the cis- and trans-permethrin isomers and their major urinary metabolites in rats

Marie‐Emilie Willemin, Sophie Desmots, R. Le Grand et al. · Toxicology and Applied Pharmacology · 2016 · 31 citations

, , +9

Determination of cis-permethrin, trans-permethrin and associated metabolites in rat blood and organs by gas chromatography–ion trap mass spectrometry

François Lestremau, Marie‐Emilie Willemin, Claudine Chatellier et al. · Analytical and Bioanalytical Chemistry · 2014 · 25 citations

, , +12

Development of 4‐Pyridoxic Acid PBPK Model to Support Biomarker‐Informed Evaluation of OAT1/3 Inhibition and Effect of Chronic Kidney Disease

Shawn Pei Feng Tan, Marie‐Emilie Willemin, Jan Snoeys et al. · Clinical Pharmacology & Therapeutics · 2023 · 21 citations · Full text

, , +17

In vitro human metabolism of permethrin isomers alone or as a mixture and the formation of the major metabolites in cryopreserved primary hepatocytes

Marie‐Emilie Willemin, András Kádár, Georges de Sousa et al. · Toxicology in Vitro · 2015 · 18 citations

, , +13

1–5 of 10